BORGATTI, Monica
 Distribuzione geografica
Continente #
NA - Nord America 26.754
AS - Asia 15.256
EU - Europa 12.474
SA - Sud America 2.470
Continente sconosciuto - Info sul continente non disponibili 710
AF - Africa 338
OC - Oceania 50
AN - Antartide 1
Totale 58.053
Nazione #
US - Stati Uniti d'America 26.117
SG - Singapore 5.570
FI - Finlandia 4.212
CN - Cina 4.115
BR - Brasile 1.969
IT - Italia 1.879
VN - Vietnam 1.545
DE - Germania 1.321
HK - Hong Kong 1.215
UA - Ucraina 1.198
PL - Polonia 1.181
TR - Turchia 815
GB - Regno Unito 751
SE - Svezia 501
FR - Francia 492
RU - Federazione Russa 372
JP - Giappone 364
IN - India 326
CA - Canada 313
BD - Bangladesh 302
ID - Indonesia 236
MX - Messico 204
AR - Argentina 175
NL - Olanda 133
ZA - Sudafrica 119
IQ - Iraq 104
PK - Pakistan 96
EC - Ecuador 87
ES - Italia 84
CO - Colombia 68
PH - Filippine 61
MY - Malesia 60
BE - Belgio 59
IR - Iran 57
VE - Venezuela 56
UZ - Uzbekistan 54
MA - Marocco 47
SA - Arabia Saudita 47
LT - Lituania 43
CL - Cile 42
AE - Emirati Arabi Uniti 39
AT - Austria 39
AU - Australia 37
TN - Tunisia 33
PY - Paraguay 32
CH - Svizzera 30
KE - Kenya 30
CZ - Repubblica Ceca 28
EG - Egitto 28
KR - Corea 28
JM - Giamaica 26
GR - Grecia 24
TH - Thailandia 22
JO - Giordania 21
CR - Costa Rica 18
IL - Israele 18
IE - Irlanda 17
ET - Etiopia 16
NP - Nepal 16
TW - Taiwan 16
OM - Oman 15
PE - Perù 15
PT - Portogallo 15
AZ - Azerbaigian 14
DZ - Algeria 14
LB - Libano 14
RO - Romania 14
KZ - Kazakistan 13
LV - Lettonia 13
PA - Panama 13
UY - Uruguay 12
BO - Bolivia 11
TT - Trinidad e Tobago 11
DO - Repubblica Dominicana 10
NG - Nigeria 10
NZ - Nuova Zelanda 10
BG - Bulgaria 9
BH - Bahrain 9
KG - Kirghizistan 9
SV - El Salvador 9
LY - Libia 8
PS - Palestinian Territory 8
RS - Serbia 8
AL - Albania 7
HN - Honduras 7
HU - Ungheria 7
KW - Kuwait 7
SI - Slovenia 7
AO - Angola 6
GE - Georgia 6
MN - Mongolia 6
NI - Nicaragua 6
SY - Repubblica araba siriana 6
EU - Europa 5
GT - Guatemala 5
MD - Moldavia 5
BB - Barbados 4
CY - Cipro 4
EE - Estonia 4
HR - Croazia 4
Totale 57.268
Città #
Helsinki 3.850
Singapore 3.458
Ashburn 3.026
Woodbridge 2.259
Fairfield 1.903
San Jose 1.808
Beijing 1.469
Chandler 1.407
Jacksonville 1.366
Ann Arbor 1.296
Houston 1.225
Hong Kong 1.191
Warsaw 1.163
Santa Clara 1.140
Wilmington 803
Seattle 778
Cambridge 628
Ferrara 517
Ho Chi Minh City 506
Izmir 477
New York 427
Nanjing 425
Los Angeles 422
Council Bluffs 403
Dallas 399
Hanoi 360
Tokyo 340
Princeton 326
Lauterbourg 273
Munich 255
Boardman 233
Milan 188
Shanghai 177
Jakarta 162
São Paulo 157
San Diego 156
Bremen 154
Addison 151
Bologna 145
Nanchang 123
Mexico City 122
Shenyang 120
Orem 106
Toronto 99
London 97
Tianjin 93
Turku 93
Brooklyn 85
Changsha 85
Hebei 84
Redwood City 82
Porto Alegre 79
Buffalo 78
Chennai 78
Montreal 77
Da Nang 75
Hefei 74
Falls Church 73
Rio de Janeiro 73
Jiaxing 68
Denver 67
Frankfurt am Main 67
Moscow 66
Chicago 65
Johannesburg 64
Stockholm 64
Haiphong 63
Guangzhou 61
Rome 61
Dearborn 60
Phoenix 59
San Francisco 59
The Dalles 59
Brussels 56
Mountain View 54
Atlanta 53
Jinan 51
Falkenstein 49
Tashkent 49
Baghdad 47
Poplar 46
Auburn Hills 45
Hangzhou 42
Manchester 42
Boston 41
Verona 41
Belo Horizonte 38
Des Moines 37
Norwalk 37
Guayaquil 36
Mumbai 36
Zhengzhou 36
Curitiba 35
Dong Ket 35
Ningbo 34
Nuremberg 34
Ferrara di Monte Baldo 33
San Mateo 33
Amsterdam 32
Brasília 32
Totale 39.206
Nome #
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 2.025
Use of angelicin and of its structural analogues for the treatment of thalassemia 1.978
A validated cellular biobank for β-thalassemia 419
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 418
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 381
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 377
Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia 373
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 369
CARATTERIZZAZIONE CHIMICA E BIOATTIVITÀ DI PREPARAZIONI TRADIZIONALI DI DROGHE AYURVEDICHE: HEMIDESMUS INDICUS E AZADIRACHTA INDICA 309
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 309
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 301
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 301
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 282
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 278
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 271
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 265
A dielectrophoretic microchip for controlled cell targeting with functionalized microspheres 263
SPR-based non-invasive prenatal testing for fetal sex determination 263
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 260
Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity 259
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 253
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 251
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 249
A peptide nucleic acid against microrna miR-145-5p enhances the expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells 246
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 245
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 244
Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis 241
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 238
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 237
Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines 237
Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA 237
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 235
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 234
Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum 231
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 230
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 228
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 227
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 227
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 227
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 225
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 225
Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin 224
Biosensor technology and surface plasmon resonance for real-time detection of genetically modified Roundup Ready soybean gene sequences 223
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 223
Targeting Transcription Factor Activity as a Strategy to Inhibit Pro-Inflammatory Genes Involved in Cystic Fibrosis: Decoy Oligonucleotides and Low-Molecular Weight Compounds 222
The biocompatibility of materials used in printed circuit board technologies with respect to primary neuronal and K562 cells 221
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 221
Expression of Pro-inflammatory Interleukin-8 is Reduced by Ayurvedic Decoctions 221
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 220
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 218
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 218
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 217
Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen 216
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae 215
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 215
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 212
Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells 211
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 210
Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites 208
A NOVEL USE OF RAPAMYCN AND STRUCTURAL ANALOGUES THEREOF 208
Regulation of IL-8 gene expression in gliomas by microRNAs 205
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 204
Liposomes as carriers for DNA-PNA hybrids 203
Antiproliferative and Erythroid Differentiation Activities of Cedrus libani Seed Extracts against K562 Human Chronic Myelogenus Leukemia Cells 203
Digital microfluidic devices for isothermal circular strand displacement polymerization of microRNAs 203
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 202
Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles 201
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 201
New trends in non-invasive prenatal diagnosis: Applications of dielectrophoresis-based Lab-on-a-chip platforms to the identification and manipulation of rare cells (Review) 200
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 199
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 196
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 195
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 194
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 194
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 193
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 193
Plants with antitumor properties:from biologically active molecules to drugs 192
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 191
Cellulose acetate microparticles for Lab-on-a-chip applications 190
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 190
Cellular biosensors for the identification of fetal hemoglobin inducers 189
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 189
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 189
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 189
Development of microRNA based protocols for detection of autologous blood transfusion in sport 189
Gene Modulation by Peptide Nucleic Acids (PNAs) Targeting microRNAs (miRs) 188
Alteration of microRNA biological activity with peptide nucleic acid 188
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 188
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 185
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 183
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 183
Effects of Medicinal Plant Extracts on Molecular Interactions between DNA and Transcription Factors 182
Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites 182
"Lethal kiss” on a dielectrophoresis (DEP) based Lab-on-a-chip device: two-colour real-time determination of cytotoxic T-lymphocyte activity. 181
Development and molecular characterization of transgenic mice for beta-thalassemia 180
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 179
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 177
A peptide nucleic acid targeting the acpP gene of Pseudomonas aeruginosa inhibits bacterial induced biological alterations in cystic fibrosis cells 177
Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site 177
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 176
Totale 26.411
Categoria #
all - tutte 245.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.196
Totale 252.811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.898 0 279 157 105 212 161 156 139 126 279 349 935
2022/20233.300 353 266 81 444 569 447 150 298 367 33 160 132
2023/20241.875 142 262 79 49 211 366 119 87 31 30 76 423
2024/20257.091 182 189 580 355 789 556 239 381 1.199 816 955 850
2025/202623.264 1.905 791 1.605 2.377 2.748 1.285 2.384 1.167 5.634 2.270 753 345
2026/20271.112 575 537 0 0 0 0 0 0 0 0 0 0
Totale 58.053